ELOX | OTC | CIK: 0001035354 | SIC: 2836 Biological Products, (No Diagnostic Substances) | active
Eloxx Pharmaceuticals, Inc. is a pharmaceutical company filing a comprehensive Annual Report covering fiscal years 2023, 2024, and 2025 as part of efforts to become current in SEC filing obligations. The filing represents their first periodic SEC submission since a Form 10-Q filed November 13, 2023. Specific products, services, and business operations are not described in the provided Item 1 excerpt.
Origin — Data Provenance
This profile was extracted from SEC EDGAR filings (PEM-signed by sec.gov).
Every API response includes a cryptographic origin leaf for chain-of-custody tracking. AI Discovery Document | Registry Metrics | GitHub